CFO
IBRX icon

Collective Family Office’s ImmunityBio IBRX Stock Holding History

Collective Family Office’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
157,200
+4,693
+3% +$35.5K 0.28% 66
2026
Q1 		$1.17M Sell
152,507
-4,323
-3% -$29.6K 0.26% 67
2025
Q4 		$311K Sell
156,830
-4,450
-3% -$10.1K 0.07% 133
2025
Q3 		$397K Buy
161,280
+18,900
+13% +$48.7K 0.1% 121
2025
Q2 		$376K Buy
142,380
+38,210
+37% +$103K 0.1% 124
2025
Q1 		$314K Buy
104,170
+15,340
+17% +$46.5K 0.08% 129
2024
Q4 		$227K Buy
88,830
+9,467
+12% +$39.4K 0.06% 152
2024
Q3 		$295K Buy
79,363
+9,008
+13% +$41.7K 0.08% 148
2024
Q2 		$445K Buy
+70,355
New +$464K 0.13% 117

Other funds holding IBRX

SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MWM
MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
DKCM
Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Collective Family Office's IBRX Position: Q2 2026 in Review

Collective Family Office increased its ImmunityBio (IBRX) stake by 3.1% in Q2 2026, buying an estimated $35.5K and bringing the position to 157,200 shares worth $1.38M. The position accounts for 0.28% of the portfolio, ranked #66.

Collective Family Office first reported a position in IBRX in Q2 2024 and has held it in 9 quarters since. 80 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Collective Family Office held 157,200 shares of ImmunityBio worth $1.38M as of Q2 2026.
  • Collective Family Office bought 4,693 ImmunityBio shares in Q2 2026, an estimated $35.5K.
  • ImmunityBio made up 0.28% of Collective Family Office's portfolio in Q2 2026, its #66 holding.
  • Collective Family Office first reported a position in ImmunityBio in Q2 2024 and has held it in 9 quarters since.
  • 80 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Collective Family Office's 13F filing for Q2 2026, filed 2 Jul 2026.